Aclarion (ACON) Other financing activities (2021 - 2026)

Aclarion's (ACON) quarterly Other financing activities came in at $9.3 million in Q1 2026, up 2671.36% YoY from $336441.0 in Q1 2025, and up 2671.36% on a QoQ basis from $336441.0 in Q1 2025.

Aclarion (ACON) Other financing activities (2021 - 2026) Analysis & Trends

Aclarion (ACON) has 3 years of Other financing activities data on file, last reported at $9.3 million in Q1 2026.

  • Quarterly Other financing activities rose 2671.36% year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (up 2671.36% YoY) and the FY2025 annual result came in at $336441.0, changed N/A from the prior year.
  • Other financing activities climbed to $9.3 million in Q1 2026, from $336441.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $9.3 million in Q1 2026 to a low of $336441.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 Aclarion 6.06 Mn 6.06 Mn 8,297.00

Historic Data

Download Data
DateValue
Mar 31, 2026 9.32 Mn
Mar 31, 2026 9.32 Mn
Mar 31, 2025 336,441.00
Mar 31, 2025 336,441.00
Jun 30, 2021 23,238.00
Jun 30, 2021 23,238.00
Mar 31, 2021 7,155.00
Mar 31, 2021 7,155.00